Clinical and Metabolic Study in Diabetic Patients Treated with Glibenclamide
- 6 June 1970
- Vol. 2 (5709) , 568-570
- https://doi.org/10.1136/bmj.2.5709.568
Abstract
A clinical and metabolic study of 32 patients treated with glibenclamide for a period of about one year confirmed that the drug is a potent stimulator of insulin release in maturity onset diabetes, and glibenclamide continued to have this action after a period of eight months. The drug is effective in doses as low as 2·5 mg., and the maximum effective dose is about 15 mg. No significant side-effects were found during the period of the study, in particular there was no alcohol flushing. The metabolic investigations have shown that the drug has some actions which are as yet unexplained.Keywords
This publication has 9 references indexed in Scilit:
- The Pattern of Response of Plasma Insulin and Glucose to Meals and Fasting During Chlorpropamide TherapyAnnals of Internal Medicine, 1968
- Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*Journal of Clinical Investigation, 1967
- [A new highly-active oral antidiabetic].1966
- The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetesMetabolism, 1966
- Immunoassay of insulin with insulin-antibody precipitateBiochemical Journal, 1963
- FATTY-ACID COMPOSITION OF LIPID FRACTIONS IN DIABETIC SERUMThe Lancet, 1963
- ALCOHOL SENSITIVITY IN DIABETICS RECEIVING CHLORPROPAMIDE1962
- Compounds administered orally in the treatment of diabetes mellitus.1960
- A RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSEJournal of Clinical Investigation, 1956